Neuralink’s Mind-Blowing Impact: Elon Musk’s Biotech Venture Could Revolutionize The Workplace, But At What Cost?
NOVEMBER 26, 2023
Elon Musk’s biotech startup Neuralink began recruitment earlier this year for its first human clinical trial after receiving approval from an independent review board. This technology could revolutionize how people interact with digital devices and systems in the future of work. If successful, it could pave the way for a new era where physical interaction with computers becomes less necessary, and thought-based commands become the norm.